Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol vs Sevoflurane in Brain Tumor Craniotomy
NCT05141877Phase 4Unknown
- Sponsor
- Kaohsiung Medical University Chung-Ho Memorial Hospital
- Start
- Feb 2022
- Primary completion
- Nov 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of propofol injection (veterinary) in primary brain tumor (2 arms), sponsored by Kaohsiung Medical University Chung-Ho Memorial Hospital. Primary endpoint: Overall Survival at 3 years. Status: unknown.
02
Drugs
propofol injection (veterinary)
03
Conditions
primary brain tumor
Beyond the preview
Go deeper on NCT05141877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05141877.